STAT3 protein inhibitors companion diagnostic - GLG Pharma
Latest Information Update: 07 Mar 2016
At a glance
- Originator GLG Pharma
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer
Most Recent Events
- 11 Jan 2016 Preclinical trials in Breast cancer (Diagnosis) in Poland (unspecified route)